230 related articles for article (PubMed ID: 23879627)
21. A robust transfection reagent for the transfection of CHO and HEK293 cells and production of recombinant proteins and lentiviral particles - PTG1.
Gonçalves C; Gross F; Guégan P; Cheradame H; Midou P
Biotechnol J; 2014 Nov; 9(11):1380-8. PubMed ID: 25215936
[TBL] [Abstract][Full Text] [Related]
22. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.
Doering CB; Denning G; Dooriss K; Gangadharan B; Johnston JM; Kerstann KW; McCarty DA; Spencer HT
Mol Ther; 2009 Jul; 17(7):1145-54. PubMed ID: 19259064
[TBL] [Abstract][Full Text] [Related]
23. Deep sequencing reveals different compositions of mRNA transcribed from the F8 gene in a panel of FVIII-producing CHO cell lines.
Kaas CS; Bolt G; Hansen JJ; Andersen MR; Kristensen C
Biotechnol J; 2015 Jul; 10(7):1081-9. PubMed ID: 25963793
[TBL] [Abstract][Full Text] [Related]
24. IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines.
Ho SC; Bardor M; Feng H; Mariati ; Tong YW; Song Z; Yap MG; Yang Y
J Biotechnol; 2012 Jan; 157(1):130-9. PubMed ID: 22024589
[TBL] [Abstract][Full Text] [Related]
25. [Expression of B domain-deleted human coagulant factor VIII gene in 293T cells mediated by lentiviral vector in vitro].
Cheng H; Xu KL; Sun HY; DU B; Zeng LY; Lu QX; He XP; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1074-8. PubMed ID: 17956694
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII.
Spencer HT; Denning G; Gautney RE; Dropulic B; Roy AJ; Baranyi L; Gangadharan B; Parker ET; Lollar P; Doering CB
Mol Ther; 2011 Feb; 19(2):302-9. PubMed ID: 21081907
[TBL] [Abstract][Full Text] [Related]
27. Lengthening of high-yield production levels of monoclonal antibody-producing Chinese hamster ovary cells by downregulation of breast cancer 1.
Matsuyama R; Yamano N; Kawamura N; Omasa T
J Biosci Bioeng; 2017 Mar; 123(3):382-389. PubMed ID: 27742176
[TBL] [Abstract][Full Text] [Related]
28. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene.
Oh TK; Quan GH; Kim HY; Park F; Kim ST
Am J Nephrol; 2006; 26(4):326-34. PubMed ID: 16825758
[TBL] [Abstract][Full Text] [Related]
29. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?
Chusainow J; Yang YS; Yeo JH; Toh PC; Asvadi P; Wong NS; Yap MG
Biotechnol Bioeng; 2009 Mar; 102(4):1182-96. PubMed ID: 18979540
[TBL] [Abstract][Full Text] [Related]
30. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells.
Herder C; Tonn T; Oostendorp R; Becker S; Keller U; Peschel C; Grez M; Seifried E
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2266-72. PubMed ID: 14551158
[TBL] [Abstract][Full Text] [Related]
31. Highly sialylated recombinant human erythropoietin production in large-scale perfusion bioreactor utilizing CHO-gmt4 (JW152) with restored GnT I function.
Goh JS; Liu Y; Liu H; Chan KF; Wan C; Teo G; Zhou X; Xie F; Zhang P; Zhang Y; Song Z
Biotechnol J; 2014 Jan; 9(1):100-9. PubMed ID: 24166780
[TBL] [Abstract][Full Text] [Related]
32. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
[TBL] [Abstract][Full Text] [Related]
33. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
34. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
[TBL] [Abstract][Full Text] [Related]
35. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII].
Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):457-9. PubMed ID: 11877017
[TBL] [Abstract][Full Text] [Related]
36. Lentiviral vector-mediated genetic modification of cell substrates for the manufacture of proteins and other biologics.
Baranyi L; Roy A; Embree HD; Dropulic B
PDA J Pharm Sci Technol; 2010; 64(5):379-85. PubMed ID: 21502041
[TBL] [Abstract][Full Text] [Related]
37. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
Kolind MP; Nørby PL; Berchtold MW; Johnsen LB
J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947
[TBL] [Abstract][Full Text] [Related]
38. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
39. Cre-Mediated Transgene Integration in Chinese Hamster Ovary Cells Using Minicircle DNA Vectors.
Wang X; Kawabe Y; Hada T; Ito A; Kamihira M
Biotechnol J; 2018 Jul; 13(7):e1800063. PubMed ID: 29701326
[TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of a codon-optimized blood coagulation factor VIII.
Shestopal SA; Hao JJ; Karnaukhova E; Liang Y; Ovanesov MV; Lin M; Kurasawa JH; Lee TK; Mcvey JH; Sarafanov AG
J Thromb Haemost; 2017 Apr; 15(4):709-720. PubMed ID: 28109042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
